Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 71335-2471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-2471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Da593f77 0b56 4eee B348 1c503d3588db 01)

Image (Da593f77 0b56 4eee B348 1c503d3588db 01)
Chemical structure diagram showing the molecular structure of Mirtazapine. The structure includes fused ring systems with nitrogen atoms, representing the active ingredient Mirtazapine.*
FDA Label Image

Label (Lbl713352471)

Label (Lbl713352471)
Label for Mirtazapine Orally Disintegrating Tablets, USP, 30 mg strength. The label indicates a package containing 30 tablets. It shows the NDC number 71335-2471-1 and states that the product is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Square Pharmaceuticals Ltd. Storage instructions and a reminder to keep out of reach of children are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.